Millendo Therapeutics, Inc. (NasdaqCM:MLND) will look for acquisition opportunities. Millendo filed for an offering of $200 million. Millendo may also use a portion of the net proceeds to invest in or acquire businesses or technologies that we believe are complementary to the company.